Abstract

The efficiency of sildenafil citrate, an oral agent for the treatment of erectile dysfunction, has been demonstrated in global studies, this randomised, double blind, placebo controlled, parlled, group, flexible dose study assessed the efficacy and safety of sildenafil to treat erectile dysfunction in men. Numerous articles have suggested that it improves endothelial function and a possible role in premature eujactulation or teatment of lower urinary tract symptoms. Drug approval and market development of sildenafil showed promise as an oral treatment for erectile dysfunction and it was lanced by pfizer as viagra. It is associated with rapid onset of action with in 14 minutes for some men and an extended duration of action for upto 12 hours.

Keywords: Phosphodiesterase Inhibitors; Safety; Side Effects; Viagra; Erectile Dysfunction

References

1. https://www.drugs.com/monograph/sildenafil-citrate.html
2. https://www.pharmaceutical-journal.com//news-and analysis/infographics/three-decades-of-viagra/20202847. fullarticle?firstPass=false
3. https://www.viagra.com/learning/what-is-ed Viagra FDA product monograph (sildenafil citrate) tablets.
4. https://www.webmd.com/drugs/2/drug-7418/sildenafil oral/details

Citation

Citation: Lokesh Masagiri., et al. “Brief Review on Sildenafil".Acta Scientific Pharmaceutical Sciences 4.1 (2020): 25-27.